A combination of the breast cancer drugs Herceptin and Tykerb may slow the progression of the disease, a recent study suggests. In a study of 300 women, those who received the drug combo went 12 weeks without their condition worsening, compared to eight weeks in the women who took Tykerb alone. But researchers say the combination of drugs also increased the risk of side effects, including a small decrease in the heart's pumping power.
Read moreThose of us in business know that time is money. Increased efficiency, spending less time on any one project, yields a greater ROI: return... Read more »
If you’re a woman with HER2 positive breast cancer, stand up right now and cheer: Tykerb, a new drug approved this week by the FDA, has... Read more »
Q. I've been taking Herceptin for quite some time for my advanced HER2-positive breast cancer. The Herceptin worked for awhile, but... Read more »
When Sarah Park, our producer here at HealthCentral, asked me if I would be interested in writing a post about a trial of lapatinib (trade... Read more »
The annual San Antonio Breast Cancer Symposium (SABCS), held last month, is the premier scientific symposium in the world for breast... Read more »
Patients who have inflammatory breast cancer that has not responded to chemotherapy or to Herceptin may be helped by trying Tykerb, researchers say.... Read more »
Source: Breastcancer.org
Brand name: Tykerb Chemical name: Lapatinib Class: HER2 (human epidermal receptor 2) inhibitor targeted therapy. Herceptin is another HER2... Read more »
Source: Breastcancer.org
Tykerb (chemical name: lapatinib) has been approved by the U.S. Food and Drug Administration (FDA): to be given in combination with Xeloda (chemical... Read more »
Source: Breastcancer.org
Tykerb can cause some side effects that are usually not severe and can be treated successfully. The most common side effects... Read more »
Source: Breastcancer.org
Tykerb can work in people with advanced HER2-positive breast cancers that have stopped responding to anthracyclines, taxanes, and Herceptin. Tykerb... Read more »